Clinical trial · Interventional
mHealth Intervention for Pain Self Management
PsyMINT: Mobile Health (mHealth) Intervention to Support Self-Management of Pain and Symptoms for Cancer Survivors
NCT07332377CI-TRIAL-00105788PsyMINTcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260915-000001
Summary
Brief summary (as posted)
This is a feasibility pilot test of a single-arm intervention to evaluate the beta version of an mHealth app-based behavioral intervention prior to scaling for a randomized controlled trial (RCT). This mHealth intervention is designed to enhance self-efficacy and support pain and symptom self-management among post-treatment cancer survivors.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivorship | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
| Pain Management | — | UNRESOLVED | — |
| Symptom Management | — | UNRESOLVED | — |
| Symptom Monitoring | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mobile Health (mHealth) Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Mobile Health (mHealth) Intervention
- description
- Implement a bank of 60 mHealth intervention messages, ecological momentary assessments (EMAs), and e-diary entries to PiLR to deliver a 1-week mHealth intervention to cancer survivors experiencing pain
- interventionNames
- Behavioral: Mobile Health (mHealth) Intervention
Primary outcomes (1)
- measure
- Feasibility and acceptability of the mobile health (mHealth) intervention
- timeFrame
- Baseline and end of one week intervention
- description
- The feasibility and acceptability of the behavioral intervention will be assessed using a pre-validated measure, the 19-item Post-Study System Usability Questionnaire (PSSUQ)87 (e.g., "It was simple to use this app") on a 7-point Likert scale. Acceptability and feasibility outcomes will be evaluated through analysis of mean scores and proportions, including: * Proportion of participants retained, * Proportion who complete at least 80% of EMAs, * 19-item Post-Study System Usability Questionnaire (PSSUQ) mean scores to be greater than 5 (as indicators of feasibility and acceptability).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * In a post-treatment stage with no evidence of disease (complete remission) * Diagnosed with cancer in the past three years * Experiencing cancer/treatment-related pain * ≥ 18 years of age at the time of first diagnosis * Cognitively able to actively participate in an online-based study * Able to read, write, and understand English Exclusion Criteria: * Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers) * Patients with major psychotic disorders (bipolar disorder or schizophrenia) and/or substance use disorders. * Those who are currently pregnant or plan to become pregnant in the next three months
References
Publications (0)
Data not yet available
No reference posted for this study.